Toman fish supplement tested to boost albumin in TB patients

NCT ID NCT07186478

Ongoing Disease control Sponsor: Hasanuddin University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests I-FALMIN, a supplement made from toman fish, in 112 adults with pulmonary tuberculosis and low albumin levels. Participants take the supplement or a placebo for one day alongside standard TB treatment. Researchers will check if albumin levels and body mass index improve over 57 days, aiming to see if this natural supplement can aid recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: I-FALMIN (standardized extract from toman fish, containing natural albumin)
What this could lead to: If it works, this could provide a natural, affordable supplement to improve albumin levels and recovery in tuberculosis patients.
What could go wrong: This is an early-stage trial with only 112 participants, so results may not apply broadly. The supplement is tested for just one day, and long-term benefits or risks are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOALBUMINEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypoalbuminemia pulmonary tuberculosis tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPOALBUMINEMIA PULMONARY TUBERCULOSIS

Contacts and locations

Locations

RSUD Wahidin Sudirohusodo

Makassar, South Sulawesi, 90245, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.